Title : The clinical importance of neutralizing antibodies in relapsing-remitting multiple sclerosis.

Pub. Date : 2006 Feb

PMID : 16466595






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The odds of relapse during a NAb+ period are between 1.51 and 1.58 (p < 0.03) with the time to first relapse being shortened by an average of 244 days after 12 months of IFN-beta therapy. nab interferon beta 1 Homo sapiens